Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lymphocyte signaling: Cbl sets the threshold for autoimmunity.

C E Rudd1, H Schneider

  • 1Division of Tumor Immunology, Department of Cancer Immunology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, 02115, USA. christopher_rudd@dfci.harvard.edu

Current Biology : CB
|May 10, 2000
PubMed
Summary

Cbl-b, a key immune regulator, acts as a ubiquitin-protein ligase. Studies show Cbl-b deficiency in mice prevents autoimmunity by controlling T and B cell signaling thresholds.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lithium salts as a treatment for COVID-19: Pre-clinical outcomes.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2022
Same author

A role for adhesion and degranulation-promoting adapter protein in collagen-induced platelet activation mediated via integrin α(2) β(1).

Journal of thrombosis and haemostasis : JTH·2011
Same author

Phosphatidylinositol-3 kinase inhibitors reproduce the selective antiproliferative effects of imatinib on chronic myeloid leukaemia progenitor cells.

British journal of haematology·2004
Same author

CD28 signaling via VAV/SLP-76 adaptors: regulation of cytokine transcription independent of TCR ligation.

Immunity·2002
Same author

Cytotoxic T lymphocyte antigen 4 and CD28 modulate cell surface raft expression in their regulation of T cell function.

The Journal of experimental medicine·2001
Same author

Lnk adaptor: novel negative regulator of B cell lymphopoiesis.

Science's STKE : signal transduction knowledge environment·2001

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Signaling

Background:

  • Cbl proteins are negative regulators of immune signaling pathways.
  • Recent findings indicate Cbl's role as a ubiquitin-protein ligase.
  • The specific function of Cbl-b in immune cell regulation was not fully understood.

Purpose of the Study:

  • To investigate the role of Cbl-b in immune signaling.
  • To determine if Cbl-b influences the threshold of T and B cell activation.
  • To explore the potential of Cbl-b in preventing autoimmune diseases.

Main Methods:

  • Analysis of Cbl-b-deficient mouse models.
  • Assessment of immune cell signaling pathways (T cells and B cells).
  • Evaluation of autoimmune disease development in the context of Cbl-b deficiency.

Related Experiment Videos

Main Results:

  • Cbl-b functions as a ubiquitin-protein ligase.
  • Cbl-b deficiency alters the signaling threshold in T and B lymphocytes.
  • Absence of Cbl-b prevents the development of autoimmunity in mice.

Conclusions:

  • Cbl-b is a critical regulator of immune cell signaling thresholds.
  • Cbl-b plays a crucial role in preventing autoimmunity.
  • Targeting Cbl-b may offer therapeutic strategies for autoimmune disorders.